Gainers

• SciSparc (NASDAQ:SPRC) shares rose 31.7% to $12.46 during Thursday's pre-market session. The company's market cap stands at $5.3 million.
• BioLine Rx (NASDAQ:BLRX) shares rose 14.93% to $3.77. The company's market cap stands at $14.2 million.
• Propanc Biopharma (NASDAQ:PPCB) shares increased by 11.31% to $1.82. The market value of their outstanding shares is at $3.7 million.
• CytoSorbents (NASDAQ:CTSO) stock moved upwards by 10.38% to $0.54. The market value of their outstanding shares is at $30.7 million.
• ABVC BioPharma (NASDAQ:ABVC) stock increased by 9.37% to $1.4. The market value of their outstanding shares is at $33.2 million.
• Cumberland Pharma (NASDAQ:CPIX) stock increased by 8.73% to $6.1. The market value of their outstanding shares is at $84.0 million.

Losers

• ADC Therapeutics (NYSE:ADCT) stock declined by 53.6% to $1.43 during Thursday's pre-market session. The company's market cap stands at $391.7 million.
• Basel Medical Group (NASDAQ:BMGL) stock declined by 26.82% to $0.48. The company's market cap stands at $12.3 million.
• Picard Medical (AMEX:PMI) stock fell 16.78% to $0.26. The company's market cap stands at $28.7 million.
• Genenta Science (NASDAQ:GNTA) shares decreased by 13.73% to $1.82. The company's market cap stands at $49.4 million.
• Virax Biolabs Group (NASDAQ:VRAX) stock declined by 13.37% to $0.21. The company's market cap stands at $1.7 million.
• SINTX Technologies (NASDAQ:SINT) shares declined by 12.4% to $1.96. The market value of their outstanding shares is at $9.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.